Lab Reports: Numbers Alone Do Not Define Patient Health

By Simone Carter

Dr. Monica Therese Cating-Cabral's recent commentary in the Daily Tribune highlights the limitations of relying solely on laboratory test values to assess patient health. While metrics like glucose levels, LDL cholesterol, and creatinine are critical for diagnosis and treatment, they fail to capture the complete picture of a patient's well-being.

Cating-Cabral argues that these numbers should initiate discussions rather than define a patient's identity. She emphasizes the importance of considering patients' habits, fears, and lifestyles alongside lab results to provide comprehensive care.

Supporting this perspective, a 2024 analysis by Bjørn Hofmann warns against the over-medicalization of biomarkers, a market projected to grow from $43.3 billion in 2020 to $92.1 billion by 2025. Hofmann points out that over-reliance on these metrics can lead to over-diagnosis and unnecessary anxiety.

Further, Mario Plebani's 2009 review on laboratory errors reveals that while analytical precision is high, with error rates as low as 0.002%, most mistakes occur in pre- and post-analytical stages. These findings underscore that even accurate numbers can be misleading without proper context and communication.

Both Hofmann and Plebani's research supports Cating-Cabral's call for a patient-centered approach, where lab results are integrated into a broader understanding of health.